Neonatal jaundice. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: Case group I: In addition to phototherapy, 10 mg/kg loading dose of phenobarbital was prescribed on first day followed by 5 mg/kg/day until the treatment of jaundice plus phototherapy.
Treatment - Drugs
Case group I: In addition to phototherapy, 10 mg/kg loading dose of phenobarbital was prescribed on first day followed by 5 mg/kg/day until the treatment of jaundice plus phototherapy.
Case group II: In addition to phototherapy, 3.5 mg/day phenobarbital was prescribedfrom day 1 until the treatment of jaundice plus phototherapy.
Control Group: Until the treatment of jaundice, Just received phototherapy.
Sponsors
Qazvin University of Medical Science
Eligibility
Sex/Gender
All
Age
3 Days to 5 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: Term neonate (> 37 weeks); Weight >= 2500 g; Indirect hyperbilirubinemia (Total bilirubin level: 17-20 mg/dL); Indication for phototherapy Exclusion criteria: Hemolysis from any cause; Metabolic and endocrine disorders; Genetic or chromosomal disorders; Sepsis; Blood transfusions; Any previous traditional drug therapy or phototherapy ; Vitamin K deficiency or bleeding in newborns; History of taking vitamin K by the mother during pregnancy; Discharge of infants with personal consent of parents before completion of treatment; Lack of parental consent for treatment or study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total serum bilirubin levels. Timepoint: before, 24 and 48 hours after the initiation of treatment. Method of measurement: Blood test.;Duration of hospitalization. Timepoint: Discharge time. Method of measurement: Patient file. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNafiseh Ataie
Qazvin University of Medical Science
Outcome results
None listed